Thomas Licher

403 total citations
12 papers, 141 citations indexed

About

Thomas Licher is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Thomas Licher has authored 12 papers receiving a total of 141 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 3 papers in Cellular and Molecular Neuroscience and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Thomas Licher's work include Ion channel regulation and function (7 papers), Cardiac electrophysiology and arrhythmias (3 papers) and Innovative Microfluidic and Catalytic Techniques Innovation (2 papers). Thomas Licher is often cited by papers focused on Ion channel regulation and function (7 papers), Cardiac electrophysiology and arrhythmias (3 papers) and Innovative Microfluidic and Catalytic Techniques Innovation (2 papers). Thomas Licher collaborates with scholars based in Germany, France and United States. Thomas Licher's co-authors include Patrick Friederich, Olaf Pongs, Heinz‐Werner Kleemann, Hartmut Rütten, Werner Dittrich, Matthias Löhn, Carsten Strübing, Thorsten Schmidt, Henning Vollert and Thomas Maier and has published in prestigious journals such as PLoS ONE, ACS Catalysis and British Journal of Pharmacology.

In The Last Decade

Thomas Licher

10 papers receiving 138 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Licher Germany 8 79 32 31 18 15 12 141
Valerie S. Morrison United Kingdom 6 67 0.8× 31 1.0× 41 1.3× 12 0.7× 6 0.4× 9 241
Victoria J. Barrett United Kingdom 9 80 1.0× 36 1.1× 30 1.0× 3 0.2× 10 0.7× 11 304
Dana Cucu Romania 12 199 2.5× 33 1.0× 80 2.6× 27 1.5× 12 0.8× 26 337
Karmelo M. Lulich Australia 8 102 1.3× 74 2.3× 8 0.3× 11 0.6× 12 0.8× 15 360
X. H. Liang China 9 104 1.3× 19 0.6× 23 0.7× 20 1.1× 4 0.3× 22 195
Kathleen Fillacier France 4 60 0.8× 19 0.6× 6 0.2× 7 0.4× 6 0.4× 6 518
Samuel Usher United Kingdom 5 233 2.9× 18 0.6× 4 0.1× 57 3.2× 10 0.7× 7 326
Ornella Manfra Norway 11 122 1.5× 59 1.8× 6 0.2× 9 0.5× 6 0.4× 19 237
Brian A. Droz United States 9 169 2.1× 53 1.7× 12 0.4× 65 3.6× 3 0.2× 10 318
Zhi-Sheng Jiang China 7 112 1.4× 4 0.1× 7 0.2× 29 1.6× 13 0.9× 8 363

Countries citing papers authored by Thomas Licher

Since Specialization
Citations

This map shows the geographic impact of Thomas Licher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Licher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Licher more than expected).

Fields of papers citing papers by Thomas Licher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Licher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Licher. The network helps show where Thomas Licher may publish in the future.

Co-authorship network of co-authors of Thomas Licher

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Licher. A scholar is included among the top collaborators of Thomas Licher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Licher. Thomas Licher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
4.
Korvorapun, Korkit, Thomas Maier, Armin Bauer, et al.. (2023). Site-Selective C–H Functionalization of N-Aryl and N-Heteroaryl Piperidines, Morpholines, and Piperazines Controlled by a Chiral Dirhodium Tetracarboxylate Catalyst. ACS Catalysis. 13(4). 2359–2366. 9 indexed citations
5.
Speckmeier, Elisabeth, et al.. (2022). A high-throughput screening assay for mutant isocitrate dehydrogenase 1 using acoustic droplet ejection mass spectrometry. SLAS DISCOVERY. 27(5). 298–305. 11 indexed citations
6.
Ruf, Sven, Theresa A. Kuntzweiler, Gerhard Heßler, et al.. (2021). A Solid Supported Membrane-Based Technology for Electrophysical Screening of B0AT1-Modulating Compounds. SLAS DISCOVERY. 26(6). 783–797. 8 indexed citations
7.
Bertrand, Daniel, et al.. (2016). Functional Studies of Sodium Channels: From Target to Compound Identification. Current Protocols in Pharmacology. 75(1). 9.21.1–9.21.35. 7 indexed citations
8.
Matter, Hans, et al.. (2013). Measuring Interference of Drug-Like Molecules with the Respiratory Chain: Toward the Early Identification of Mitochondrial Uncouplers in Lead Finding. Assay and Drug Development Technologies. 11(7). 408–422. 6 indexed citations
9.
Schmidt, Thorsten, Matthias Löhn, Heinz‐Werner Kleemann, et al.. (2012). Inhibition of Diacylglycerol–Sensitive TRPC Channels by Synthetic and Natural Steroids. PLoS ONE. 7(4). e35393–e35393. 38 indexed citations
10.
Geibel, Sven, et al.. (2006). Establishment of Cell-Free Electrophysiology for Ion Transporters: Application for Pharmacological Profiling. SLAS DISCOVERY. 11(3). 262–268. 12 indexed citations
11.
Schindler, Ursula, Martin Gerl, Stefan Schäfer, et al.. (2004). Inhibition of Na+–H+ exchange by cariporide reduces inflammation and heart failure in rabbits with myocardial infarction. British Journal of Pharmacology. 142(7). 1147–1154. 11 indexed citations
12.
Licher, Thomas, et al.. (2003). Inhibition of Human TREK-1 Channels by Bupivacaine. Anesthesia & Analgesia. 96(6). 1665–1673. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026